Filing Details
- Accession Number:
- 0000950170-24-140393
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-12-26 16:02:31
- Reporting Period:
- 2024-12-23
- Accepted Time:
- 2024-12-26 16:02:31
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1971543 | Mural Oncology Plc | MURA | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1693805 | Maiken Keson-Brookes | C/O Mural Oncology Plc 10 Earlsfort Terrace Dublin 2 L2 D02 T380 | See Remarks | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Disposition | 2024-12-23 | 2,555 | $3.27 | 41,295 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Represents shares automatically sold by the Reporting Person pursuant to a Rule 10b5-1 trading arrangement that was entered into by the Reporting Person on September 20, 2024.
- The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.24 to $3.33. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- Includes 38,705 unvested restricted stock units.